Shanghai Runda Medical Technology Co., Ltd.

Shanghai Stock Exchange 603108.SS

Shanghai Runda Medical Technology Co., Ltd. Capital Expenditure for the year ending December 31, 2023: USD -45.06 M

Shanghai Runda Medical Technology Co., Ltd. Capital Expenditure is USD -45.06 M for the year ending December 31, 2023, a -14.26% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Shanghai Runda Medical Technology Co., Ltd. Capital Expenditure for the year ending December 31, 2022 was USD -39.43 M, a 16.78% change year over year.
Shanghai Runda Medical Technology Co., Ltd. Capital Expenditure for the year ending December 31, 2021 was USD -47.38 M, a 6.82% change year over year.
Shanghai Runda Medical Technology Co., Ltd. Capital Expenditure for the year ending December 31, 2020 was USD -50.85 M, a -22.65% change year over year.
Shanghai Runda Medical Technology Co., Ltd. Capital Expenditure for the year ending December 31, 2019 was USD -41.46 M, a -7.84% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

Shanghai Stock Exchange: 603108.SS

Shanghai Runda Medical Technology Co., Ltd.

CEO	Mr. Cheng Xu Zhang
IPO Date	May 27, 2015
Location	China
Headquarters	Xinghui (Landmark) Center
Employees	3,315
Sector	Health Care
Industries Medical Instruments Biotechnology Hospitals & Clinics Pharmaceuticals

Description

Shanghai Runda Medical Technology Co., Ltd. provides integrated medical laboratory services in China. It offers platform supply, laboratory design/renovation, laboratory standardization, and information management system services; medical solutions to help healthcare professionals in the areas of biochemistry, diabetes, POCT, immunoassay analyzer, and molecular biology diagnosis; professional technical services; and logistic services. The company was founded in 1999 and is based in Shanghai, China.

Key trends

Past 5 years